Found vs Noom Med: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Noom Med beats Found overall, scoring 7.4/10 vs 7.3/10. Noom Med is more affordable at $99/mo vs $264/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Noom Med for users who want a tiered entry into glp-1 care — from $99/mo .

A side-by-side comparison of Found and Noom Med covering pricing, scores, medication types, insurance, and more to help you decide.

Found

#37 of 48

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

Noom Med

#28 of 48

7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Feature	Found	Noom Med
Our Score	7.3/10	7.4/10
Starting Price	$264/mo	$99/mo
Medication Type	Both	Both
Insurance Accepted	Yes	Yes
Best For	Users who want a science-backed weight loss program with behavior change support	Users who want a tiered entry into GLP-1 care — from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program
Ranking	#37	#28

Pros & Cons Compared

Found

Pros

+Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
−The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
−Compounded medication availability may shift with FDA enforcement changes

Noom Med

Pros

+Tiered 2026 entry — $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+New Microdose GLP-1Rx program ($99-149/mo) — low-dose GLP-1 + biomarker monitoring for sensitive users
+Insurance accepted for qualifying plans — can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing creates confusion — $69, $99-149, or $149-349 depending on tier
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket — the low tier price is just the platform
−App coaching still requires real engagement — skip-prone users waste the behavioral value

Our Verdict

Noom Med edges out Found with a score of 7.4/10 vs 7.3/10. If budget is your priority, Noom Med starts at $99/mo compared to Found's $264/mo. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Noom Med if you want: users who want a tiered entry into glp-1 care — from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Found nor Noom Med feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review